Latest Content From Ruairi J MacKenzie
Alzheimer’s disease (AD) is the leading cause of dementia worldwide. Classically, the “amyloid” hypothesis, which ties the disease’s spread to that of amyloid protein, is thought to underlie AD’s pathology. After years of mixed to negative results in clinical trials, new research is underway to investigate what role the brain’s own immune system plays in amyloid-driven disease; an “infl-amyloid” hypothesis.
A recent assessment of the success of the drug development process put the percentage of phase I programs that make it to approval at 13.8%. That figure points to a crisis of attrition within the industry. Netramark, a Toronto-based start-up claim they have a machine learning-powered solution to that crisisVIEW
Loud background noise doesn’t just annoy people by getting in the way of good conversation – it also affects voice activated devices. AudioTelligence, a start-up based out of Cambridge, say they have developed the world’s first digital solution to this ‘cocktail party problem’.
Marilyn Cornelis, of the Feinberg School of Medicine at Northwestern University, has spent years researching how coffee affects our body. In this interview, she explains how coffee affects our brain, interacts with cannabis, and why listening to your body might be the best way to decide how much coffee to drink.VIEW
Whilst all life sciences have benefited immensely from digitization and automation in the last ten years, tools designed specifically for biologists have been somewhat scarce. London-based Synthace are aiming to change that. In this blog, we ask Synthace co-founder Chris Grant how his company's platform Antha was developed and why it has earned Synthace a “Cool Vendor of the Year” award from Gartner.VIEW
Single Molecule Real Time (SMRT) DNA sequencing is pretty darn popular: it featured in over 1400 publications in 2017 alone. The research to create SMRT began 20 years ago, and in this article one of the technique's creators, Jonas Korlach, explains how SMRT developed from concept to technology.VIEW
Starkey Hearing Technologies recently unveiled their latest hearing aid, the Livio AI. Starkey says the device does a lot more than just assist in hearing, and includes a range of additional technology, such as a physical activity tracker and integrated language translation.
Cell-Free Technology is taking a unique approach to protein technology with their BioBits initiative, which they say combines the ease of use of a digital design tool with the detailed scientific validation provided by a CRO. We catch up with Cell-Free CEO Tom Meany to discuss the new technology.VIEW